
Satellos Presents SAT-3247 Phase 1 Data in Late-Breaking WMS Poster
Satellos Bioscience Inc., a clinical-stage biotechnology company dedicated to developing transformative therapies for degenerative muscle diseases, announced today that it will present two scientific posters at the upcoming 30th Annual Congress of the World Muscle Society (WMS), scheduled to take…